Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer

Clinical trial NCT02393755 · COMPLETED

Trial details

NCT number: NCT02393755
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colon Adenocarcinoma Rectal Adenocarcinoma Recurrent Colon Carcinoma Recurrent Rectal Carcinoma Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer

Start date: 2015-05-08
Primary completion: 2017-11-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.